TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pfizer Health AB
Closing information (x1000 NOK)
Closing information | 2023/11 | 2022/11 | 2021/11 |
Turnover |
6,482,002
|
4,011,567
|
3,232,158 |
Financial expenses |
0
|
947
|
2,000 |
Earnings before taxes |
4,042,793
|
2,549,115
|
1,236,060 |
EBITDA |
4,049,970
|
2,664,597
|
1,378,067 |
Total assets |
11,300,954
|
9,134,408
|
8,682,424 |
Current assets |
8,787,922
|
6,845,600
|
6,238,305 |
Current liabilities |
1,247,801
|
760,096
|
1,071,052 |
Equity capital |
9,842,678
|
8,177,160
|
7,397,081 |
- share capital |
2,622,740
|
2,421,328
|
2,558,125 |
Employees (average) |
340
|
325
|
311 |
Financial ratios
Fiscal year | 2023/11 | 2022/11 | 2021/11 |
Solvency |
87.1%
|
89.5%
|
85.2% |
Turnover per employee |
19,065
|
12,343
|
10,393 |
Profit as a percentage of turnover |
62.4%
|
63.5%
|
38.2% |
Return on assets (ROA) |
35.8%
|
27.9%
|
14.3% |
Current ratio |
704.3%
|
900.6%
|
582.4% |
Return on equity (ROE) |
41.1%
|
31.2%
|
16.7% |
Change turnover |
2,136,744
|
952,250
|
-1,159,057 |
Change turnover % |
49%
|
31%
|
-26% |
Chg. No. of employees |
15
|
14
|
21 |
Chg. No. of employees % |
5%
![]() |
5%
|
7% |
Total value of public sale
Fiscal year | 2023/11 | 2022/11 | 2021/11 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.